Skip to main content

Retinal Vascularity Index in Parkinson's Disease.

Journal articles  - Journal Article
Hsu, J; D'Cunha, R; Choi, A; Zhu, M; Haystead, A; Stinnett, SS; Hudlikar, A; Song, R; Ng, H; Agrawal, R; Scott, BL; Grewal, DS; Fekrat, S
Published in: Ophthalmol Sci
November 2026

PURPOSE: To assess differences in retinal vascularity index (RVI) between individuals with Parkinson's disease (PD) and controls to explore RVI as a potential retinal biomarker of PD. DESIGN: Cross-sectional case-control study. PARTICIPANTS: One hundred sixty-eight eyes of 108 PD participants and 115 eyes of 71 control participants in the Eye Multimodal Imaging in Neurodegenerative Disease Study. METHODS: Ultra-widefield (UWF) retinal color photographs were acquired in each participant using scanning laser ophthalmoscopy (California, Optos). Images were analyzed using a semiautomated software via the Comprehensive Ocular Imaging Network (ocularimaging.net). Retinal vascularity index was calculated as the ratio of arteriolar to venular cross-sectional area within a 47° region of interest (ROI) centered on the optic disc. MAIN OUTCOME MEASURES: Five RVI outcomes in the 47° ROI were compared between groups: total, superonasal, superotemporal, inferotemporal, and inferonasal (IN). RESULTS: Mean total RVI was significantly higher in the PD group (0.790 ± 0.134) than in controls (0.696 ± 0.117, P < 0.001). Retinal vascularity index in each quadrant was also significantly higher in PD than in controls: superonasal (P < 0.001), superotemporal (P = 0.005), inferotemporal (P < 0.001), and IN (P < 0.001). CONCLUSIONS: Retinal vascularity index was significantly higher in individuals with PD than in controls. These findings may reflect alterations in retinal vascular structure in PD. Discriminatory analyses suggest that RVI is currently unlikely to stand alone as a diagnostic tool. Further investigation is warranted to determine whether RVI derived from a 5-disc diameter area on UWF images may serve as a potential retinal biomarker of PD. FINANCIAL DISCLOSURES: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ophthalmol Sci

DOI

EISSN

2666-9145

Publication Date

November 2026

Volume

6

Issue

11

Start / End Page

101379

Location

Netherlands
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hsu, J., D’Cunha, R., Choi, A., Zhu, M., Haystead, A., Stinnett, S. S., … Fekrat, S. (2026). Retinal Vascularity Index in Parkinson's Disease. Ophthalmol Sci, 6(11), 101379. https://doi.org/10.1016/j.xops.2026.101379
Hsu, John, Rachel D’Cunha, Alex Choi, Michael Zhu, Alice Haystead, Sandra S. Stinnett, Atharva Hudlikar, et al. “Retinal Vascularity Index in Parkinson's Disease.” Ophthalmol Sci 6, no. 11 (November 2026): 101379. https://doi.org/10.1016/j.xops.2026.101379.
Hsu J, D’Cunha R, Choi A, Zhu M, Haystead A, Stinnett SS, et al. Retinal Vascularity Index in Parkinson's Disease. Ophthalmol Sci. 2026 Nov;6(11):101379.
Hsu, John, et al. “Retinal Vascularity Index in Parkinson's Disease.” Ophthalmol Sci, vol. 6, no. 11, Nov. 2026, p. 101379. Pubmed, doi:10.1016/j.xops.2026.101379.
Hsu J, D’Cunha R, Choi A, Zhu M, Haystead A, Stinnett SS, Hudlikar A, Song R, Ng H, Agrawal R, Scott BL, Grewal DS, Fekrat S. Retinal Vascularity Index in Parkinson's Disease. Ophthalmol Sci. 2026 Nov;6(11):101379.

Published In

Ophthalmol Sci

DOI

EISSN

2666-9145

Publication Date

November 2026

Volume

6

Issue

11

Start / End Page

101379

Location

Netherlands